N-(3-pyrrolidinyl) benzamide derivative

A novel N-(3-pyrrolidinyl)benzamide compound represented by a general formula (I), or a pharmaceutically acceptable salt thereof, ##STR120## wherein each symbol in the formula has the following meaning, R.sup.1 :

• a hydrogen atom, a lower alkyl group, an aralkyl group or a cycloalkyl or cycloalkyl-lower alkyl group having 3 to 8 ring atoms,
• R.sup.2 :
• a bicyclic or tricyclic bridged hydrocarbon ring group having 4 to 16 ring atoms, which may be substituted by a lower alkyl group(s),
• R.sup.3 :
• a lower alkoxy group, an amino group or a mono- or di-lower alkylamino group,
• R.sup.4 :
• a hydrogen atom, a halogen atom, a lower alkyl group which may be substituted by a hydroxyl group, a lower alkoxy group, a cyano group, a nitro group, an amino group, a mono- or di-lower alkylamino group, an acyl group or a group represented by --S(O).sub.m --R.sup.5,
• R.sup.5 :
• a lower alkyl group, an amino group or a mono- or di-lower alkylamino group,
• m:
• 0, 1 or 2,
• X:
• a bond or a group represented by --O--, --S(O).sub.n --, --NH--or --CONH--, and
• n:
• 0, 1 or 2,
• with the proviso that, when R.sup.1 is a cycloalkyl group, the cases wherein X is a group represented by --CONH--, R.sup.3 is a lower alkoxy group and R.sup.4 is a halogen atom are excluded.